Suppr超能文献

卵巢性索间质肿瘤的转移模式:常规分期淋巴结切除术可省略吗?

Patterns of metastasis in sex cord-stromal tumors of the ovary: can routine staging lymphadenectomy be omitted?

作者信息

Brown Jubilee, Sood Anil K, Deavers Michael T, Milojevic Ljiljana, Gershenson David M

机构信息

Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, 1155 Herman Pressler Blvd, Unit 1362, P.O. Box 301439, TX 77230-1439, USA.

出版信息

Gynecol Oncol. 2009 Apr;113(1):86-90. doi: 10.1016/j.ygyno.2008.12.007. Epub 2009 Jan 21.

Abstract

OBJECTIVE

Given the paucity of data regarding the patterns of metastasis from ovarian sex cord-stromal tumors (SCSTs), we sought to determine the risk of lymph node metastasis in patients with SCSTs.

METHODS

A retrospective chart review was performed after clinical and pathology databases were queried for ovarian SCST patients who were treated at our institution between 1985 and 2005.

RESULTS

We identified 262 patients with pathology-confirmed ovarian SCSTs; 5 had additional non-stromal histology and were excluded, leaving 257 evaluable patients. Of these patients, 178 had adult granulosa cell tumors, 27 had juvenile granulosa cell tumors, 31 had Sertoli-Leydig cell tumors, 6 had sex cord tumors with annular tubules, 13 had mixed SCSTs, and 2 had SCSTs not otherwise specified. Our evaluation showed that 111 patients underwent a complete or partial staging procedure; 75 had stage I disease, 11 had stage II disease, and 25 had stage III disease. Fifty-eight of these 111 patients (52%) had lymph nodes removed as part of the staging procedure. Of the 58 patients who had lymph nodes sampled during the primary surgery, none had positive nodes. Of 117 patients whose disease eventually recurred, 6 patients (5.1%) had nodal metastases at the time of recurrence. Three of these patients had negative lymph nodes at initial staging.

CONCLUSIONS

Lymph node metastasis in ovarian SCSTs is rare. These findings suggest that lymphadenectomy may be omitted when staging patients with ovarian SCSTs.

摘要

目的

鉴于关于卵巢性索间质肿瘤(SCSTs)转移模式的数据匮乏,我们试图确定SCSTs患者发生淋巴结转移的风险。

方法

在临床和病理数据库中查询1985年至2005年在我们机构接受治疗的卵巢SCSTs患者后,进行了一项回顾性病历审查。

结果

我们确定了262例经病理证实的卵巢SCSTs患者;5例有额外的非间质组织学特征,被排除在外,剩下257例可评估患者。在这些患者中,178例为成人颗粒细胞瘤,27例为青少年颗粒细胞瘤,31例为支持-间质细胞瘤,6例为环状小管性索肿瘤,13例为混合性SCSTs,2例为未另行指定的SCSTs。我们的评估显示,111例患者接受了完全或部分分期手术;75例为I期疾病,11例为II期疾病,25例为III期疾病。这111例患者中有58例(52%)在分期手术中切除了淋巴结。在初次手术时进行淋巴结取样的58例患者中,无一例淋巴结阳性。在117例疾病最终复发的患者中,6例(5.1%)在复发时出现了淋巴结转移。其中3例患者在初始分期时淋巴结为阴性。

结论

卵巢SCSTs发生淋巴结转移很罕见。这些发现表明,在对卵巢SCSTs患者进行分期时,可能无需进行淋巴结切除术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验